Related Experiment Video

Updated: Jun 13, 2026

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on: March 12, 2022

Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling

Renhai Cao1, Yihai Cao

  • 1Department of Microbiology, Karolinska Institute, Stockholm, Sweden.

Cell Cycle (Georgetown, Tex.)
|May 18, 2010
PubMed

Insights

Cancer-associated retinopathy (CAR) involves tumor factors that damage retinal blood vessels. Targeting these factors with anti-VEGF agents may offer a new treatment for CAR.

Area of Science:

  • Ophthalmology
  • Oncology
  • Immunology

Background:

  • Cancer-associated retinopathy (CAR) is linked to autoimmune responses against retinal antigens.
  • CAR patients often exhibit minimal ocular immunological reactions.
  • Tumor-derived factors are implicated in CAR pathogenesis.

Purpose of the Study:

  • To investigate the role of tumor-derived angiogenic factors in CAR development.
  • To identify the specific molecular pathways involved in CAR-related retinal vascular changes.
  • To explore potential therapeutic strategies for CAR.

Main Methods:

  • Analysis of tumor-derived vascular endothelial growth factor (VEGF) and placental growth factor (PlGF).
  • Assessment of retinal vascular remodeling, pericyte ablation, and blood-retinal barrier integrity.
  • Investigation of vascular endothelial growth factor receptor 1 (VEGFR1) and VEGFR2 signaling in retinal cells.

Main Results:

  • Tumor-derived VEGF and PlGF remodel retinal vasculature by causing pericyte ablation.
  • Impaired blood-retinal barrier function and increased vascular leakage were observed.
  • VEGFR1, not VEGFR2, was identified as the primary receptor mediating these vascular pathologies.

Conclusions:

  • Tumor-derived angiogenic factors play a significant role in the development of CAR.
  • VEGFR1 signaling is crucial for the vascular pathologies observed in CAR.
  • Anti-VEGF agents represent a potential therapeutic approach for treating CAR.

More Related Videos

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Retinal Pathophysiological Evaluation in a Rat Model09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...